Establishment Labs (NASDAQ:ESTA) Reaches New 1-Year Low - What's Next?

Shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA - Get Free Report) reached a new 52-week low during mid-day trading on Monday . The company traded as low as $30.20 and last traded at $35.01, with a volume of 780735 shares trading hands. The stock had previously closed at $45.79.

Analyst Ratings Changes

A number of analysts have commented on ESTA shares. Citigroup boosted their price objective on Establishment Labs from $45.00 to $50.00 and gave the stock a "neutral" rating in a report on Tuesday, October 1st. BTIG Research raised their price objective on Establishment Labs from $62.00 to $65.00 and gave the company a "buy" rating in a research note on Monday, October 14th. Finally, Stephens upgraded shares of Establishment Labs to a "strong-buy" rating in a research note on Monday, December 2nd. One research analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, Establishment Labs currently has a consensus rating of "Buy" and an average target price of $60.60.

Establishment Labs Stock Performance

The firm has a market cap of $943.81 million, a PE ratio of -13.07 and a beta of 1.15. The company has a 50-day simple moving average of $44.04 and a two-hundred day simple moving average of $43.68. The company has a quick ratio of 2.29, a current ratio of 3.62 and a debt-to-equity ratio of 5.94.

Hedge Funds Weigh In On Establishment Labs

Institutional investors have recently added to or reduced their stakes in the stock. Sofinnova Investments Inc. grew its position in shares of Establishment Labs by 204.1% during the 2nd quarter. Sofinnova Investments Inc. now owns 429,244 shares of the company's stock valued at $19,505,000 after acquiring an additional 288,082 shares during the period. Divisadero Street Capital Management LP purchased a new position in Establishment Labs in the second quarter valued at approximately $5,829,000. Millennium Management LLC increased its position in Establishment Labs by 49.8% in the second quarter. Millennium Management LLC now owns 273,605 shares of the company's stock worth $12,433,000 after buying an additional 90,943 shares during the last quarter. Rice Hall James & Associates LLC grew its stake in Establishment Labs by 10.7% in the 3rd quarter. Rice Hall James & Associates LLC now owns 793,300 shares of the company's stock valued at $34,326,000 after buying an additional 76,959 shares in the last quarter. Finally, Stonepine Capital Management LLC bought a new position in Establishment Labs in the 3rd quarter worth about $3,245,000. Institutional investors own 72.91% of the company's stock.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.